Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 4
2014 1
2015 6
2016 7
2017 12
2018 8
2019 6
2020 13
2021 14
2022 16
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Drug-Drug Interactions in Patients with Acute Respiratory Distress Syndrome.
Bischof T, Schaller C, Buchtele N, Staudinger T, Ullrich R, Kraft F, Andersson ML, Jilma B, Schoergenhofer C. Bischof T, et al. Among authors: schoergenhofer c. Pharmaceutics. 2024 Feb 21;16(3):303. doi: 10.3390/pharmaceutics16030303. Pharmaceutics. 2024. PMID: 38543197 Free PMC article.
Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge.
Scheuba A, Zagrapan B, Martelanz L, Eder V, Ibrahim N, Bleichert S, Knöbl V, Hayden H, von Kuenheim S, Münch K, Buchtele N, Schoergenhofer C, Kovacevic KD, Lackner E, Drucker C, Neumayer C, Jilma B, Brostjan C. Scheuba A, et al. Among authors: schoergenhofer c. Thromb Res. 2024 May;237:205-208. doi: 10.1016/j.thromres.2024.01.011. Epub 2024 Jan 15. Thromb Res. 2024. PMID: 38521738 Free article. No abstract available.
A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results.
Schoergenhofer C, Gelbenegger G, Hasanacevic D, Schöner L, Steiner MM, Firbas C, Buchtele N, Derhaschnig U, Tanzmann A, Model N, Larcher-Senn J, Drost M, Eibl MM, Roetzer A, Jilma B. Schoergenhofer C, et al. EClinicalMedicine. 2024 Jan 5;67:102404. doi: 10.1016/j.eclinm.2023.102404. eCollection 2024 Jan. EClinicalMedicine. 2024. PMID: 38274114 Free PMC article.
Disseminated Intravascular Coagulation in Anaphylaxis.
Gelbenegger G, Buchtele N, Schoergenhofer C, Grafeneder J, Schwameis M, Schellongowski P, Denk W, Jilma B. Gelbenegger G, et al. Among authors: schoergenhofer c. Semin Thromb Hemost. 2023 Nov 29. doi: 10.1055/s-0043-1776878. Online ahead of print. Semin Thromb Hemost. 2023. PMID: 38029783
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial.
Rathkolb V, Traugott MT, Heinzel A, Poglitsch M, Aberle J, Eskandary F, Abrahamowicz A, Mueller M, Knollmueller P, Shoumariyeh T, Stuflesser J, Seeber I, Gibas G, Mayfurth H, Tinhof V, Schmoelz L, Zeitlinger M, Schoergenhofer C, Jilma B, Genser B, Hoepler W, Omid S, Karolyi M, Wenisch C, Oberbauer R, Zoufaly A, Hecking M, Reindl-Schwaighofer R. Rathkolb V, et al. Among authors: schoergenhofer c. iScience. 2023 Oct 5;26(11):108146. doi: 10.1016/j.isci.2023.108146. eCollection 2023 Nov 17. iScience. 2023. PMID: 37867935 Free PMC article.
The Pharmacokinetics of Individual Conjugated Xanthohumol Metabolites Show Efficient Glucuronidation and Higher Bioavailability of Micellar than Native Xanthohumol in a Randomized, Double-Blind, Crossover Trial in Healthy Humans.
Buckett L, Sus N, Spindler V, Rychlik M, Schoergenhofer C, Frank J. Buckett L, et al. Among authors: schoergenhofer c. Mol Nutr Food Res. 2023 Nov;67(22):e2200684. doi: 10.1002/mnfr.202200684. Epub 2023 Sep 18. Mol Nutr Food Res. 2023. PMID: 37721120 Clinical Trial.
Effect of the human endotoxin challenge on tedizolid tissue penetration.
Jorda A, Wulkersdorfer B, Schoergenhofer C, Matzneller P, Al Jalali V, Bauer M, Wölfl-Duchek M, Lackner E, Dorn C, Jilma B, Zeitlinger M. Jorda A, et al. Among authors: schoergenhofer c. Br J Clin Pharmacol. 2023 Jan;89(1):416-420. doi: 10.1111/bcp.15564. Epub 2022 Oct 25. Br J Clin Pharmacol. 2023. PMID: 36223278 Free PMC article.
Applicability of Vasopressor Trials in Adult Critical Care: A Prospective Multicentre Meta-Epidemiologic Cohort Study.
Buchtele N, Schwameis M, Roth D, Schwameis F, Kraft F, Ullrich R, Mühlbacher J, Laggner R, Gamper G, Semmler G, Schoergenhofer C, Staudinger T, Herkner H. Buchtele N, et al. Among authors: schoergenhofer c. Clin Epidemiol. 2022 Sep 30;14:1087-1098. doi: 10.2147/CLEP.S372340. eCollection 2022. Clin Epidemiol. 2022. PMID: 36204153 Free PMC article.
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A.
Ay C, Kovacevic KD, Kraemmer D, Schoergenhofer C, Gelbenegger G, Firbas C, Quehenberger P, Jilma-Stohlawetz P, Gilbert JC, Zhu S, Beliveau M, Koenig F, Iorio A, Jilma B, Derhaschnig U, Pabinger I. Ay C, et al. Among authors: schoergenhofer c. Blood. 2023 Mar 9;141(10):1147-1158. doi: 10.1182/blood.2022016571. Blood. 2023. PMID: 36108308 Free PMC article.
82 results